In WHO Useful Class II patients, consider regardless of whether the main advantages of bosentan are adequate to offset the risk of hepatotoxicity, which can preclude upcoming use as their illness progresses.Picked from data involved with permission and copyrighted by Initially Databank, Inc. This copyrighted material has long been downloaded from t